Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Javier Simarro
Observed name:
J. Simarro
Institutions:
Hospital Universitari i Politècnic La Fe,
Instituto de Investigación Sanitaria La Fe
Observed institutions:
Hospital Universitari i Politècnic La Fe,
Instituto de Investigación Sanitaria La Fe
ORCID:
0000-0003-3155-1713
Observed ORCID:
0000-0003-3155-1713
OpenAlex ID:
A5068168981
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital
2023
·
Javier Simarro
, Gema Pérez-Simó
, et al.
·
Cancers
·
24
PDF
MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase
2021
·
Estefanía Tarazón
, Blanca de Unamuno Bustos
, et al.
·
Genes
·
22
PDF
Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital
2019
·
Javier Simarro
, Rosa Murria
, et al.
·
Cancers
·
22
PDF
Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia
2023
·
José Vicente Gil
, Esperanza Such
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Early radiological response as predictor of overall survival in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor mutations
2018
·
Carmen Salvador-Coloma
, David Lorente
, et al.
·
Journal of Thoracic Disease
·
8
PDF
Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients
2022
·
Javier Simarro
, Gema Pérez-Simó
, et al.
·
International Journal of Molecular Sciences
·
6
PDF
Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report
2022
·
Javier Simarro
, Gema Pérez-Simó
, et al.
·
Diagnostics
·
6
PDF
Pretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st or 2nd generation EGFR tyrosine kinase inhibitors (TKIs)
2019
·
O.J. Juan Vidal
, J. Simarro
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
8
Citation count:
99
H-index:
6
I10-index:
4
Year
Topic
Type